Key result
The EPA-Cardio standardized measures for cardiovascular risk management were feasible and accepted by general practices across six European countries, enabling international comparisons of primary care quality.
Population
12 European general practices and their patients (n=268 with established CHD, n=127 at high risk for CVD)
Design
Other
Authors
Loading...
May support international benchmarking of primary care CV risk management; leaves open outcome validation before routine adoption.
Observational (n=395)
Yes
An internationally standardized measure of cardiovascular risk management (EPA-Cardio) was successfully developed and piloted for feasibility in European primary care practices.
Ludt et al. (2011) conducted an observational in Cardiovascular disease and high cardiovascular risk (n=395). EPA-Cardio instrument was evaluated on Feasibility and acceptability of the EPA-Cardio measures. The EPA-Cardio standardized measures for cardiovascular risk management were feasible and accepted by general practices across six European countries, enabling international comparisons of primary care quality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: